Postural induced-tremor in psychiatry

Psychiatry and Clinical Neurosciences

Volumn 62, Issue 6, 2008, Pages 638-645

  Arbaizar, Beatriz ^a   Gómez Acebo, Inés ^b   Llorca, Javier ^b,c  

^a Laredo Hospital   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

^c UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Antidepressant; Drug induced tremor; Lithium; Neuroleptic; Valproic acid

Indexed keywords

ALCOHOL; ALPHA INTERFERON; ALPRAZOLAM; AMIODARONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN A; CIMETIDINE; CLONAZEPAM; COCAINE; CYCLOSPORIN; CYTARABINE; GABAPENTIN; IFOSFAMIDE; LAMOTRIGINE; LITHIUM; METOCLOPRAMIDE; NEUROLEPTIC AGENT; NICOTINE; PRIMIDONE; PROCAINAMIDE; PROPRANOLOL; SALMETEROL; TACROLIMUS; TAMOXIFEN; THEOPHYLLINE; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID;

AKATHISIA; ATAXIA; BEDTIME DOSAGE; BLURRED VISION; BRADYCARDIA; CILIARY EDEMA; CLINICAL TRIAL; CONFUSION; DISEASE CLASSIFICATION; DIZZINESS; DROWSINESS; DRUG ACTIVITY; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG RESPONSE; DRUG STRUCTURE; DYSTONIA; ESSENTIAL TREMOR; FATIGUE; HUMAN; IMPOTENCE; MOTION SICKNESS; NAUSEA; NEPHROLITHIASIS; NEUROPSYCHIATRY; PARESTHESIA; PARKINSONISM; PHENOMENOLOGY; POSTURAL TREMOR; REVIEW; SEDATION; SIDE EFFECT; SINGLE DRUG DOSE; SOMNOLENCE; TREMOR; VERTIGO; VOMITING;

BIOMECHANICS; HUMANS; MENTAL DISORDERS; MUSCLE, SKELETAL; PARKINSON DISEASE; PSYCHOTROPIC DRUGS; TREMOR;

EID: 56849126813     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2008.01877.x     Document Type: Review

References (67)

1. National Institute of Neurological Disorders and Stroke. Tremor Fact Sheet. National Institutes of Health. Publication No. 06-4734, 2006 Cited 25 April 2008]. Available from URL: http://www.ninds.nih.gov/disorders/tremor/ detail_tremor.htm
2. Gelenberg AJ, Kane JM, Keller MB et al. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N. Engl. J. Med. 1989 321 : 489 493.
3. Lapierre YD. Control of lithium tremor with propanolol. CMAJ 1976 114 : 619 624.
4. Raethjen J, Lemke MR, Lindermann M et al. Amitriptyline enhances the central component of physiological tremor. J. Neurol. Neurosurg. Psychiatry 2001 70 : 78 82.
5. Deuschl G, Raethjen J, Linderman M et al. The pathophysiology of tremor. Muscle Nerve 2001 14 : 716 735.
6. Bain PG. The management of tremor. J. Neurol. Neurosurg Psychiatry 2002 72 (Suppl. 3 9.
7. Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov. Disord. 1998 13 (Suppl. 3 2 23.
8. Habib-ur-Rehman. Diagnosis and management of tremor. Arch. Intern. Med. 2000 160 : 2438 2444.
9. O'Sullivan JD, Lees AJ. Nonparkinsonian tremors. Clin. Neuropharmacol. 2000 23 : 233 238.
10. Morgan JC, Kapil DS. Drug-induced tremors. Lancet Neurol. 2005 4 : 866 876.
11. Dean CE, Kuskowski MA, Caligiuri MP. Predictors of neuroleptic-induced diskinesia and parkinsonism: The influence of measurement methods and definitions. J. Clin. Psychopharmacol. 2006 26 : 560 565.
12. Rozzini L, Chilovi BV, Bertoletti E et al. Mild Parkinson signs and psycho-behavioral symptoms in subjects with mild cognitive impairment. Int. Psychogeriatr. 2008 20 : 86 95.
13. Smaga S. Tremor. Am. Fam. Physician 2003 68 : 1545 1552.
14. Budisic M, Trkanjec Z, Bosnjak J et al. Distinguishing Parkinson's disease and essential tremor with transcraneal sonography. Acta Neurol. Scand. 2008 (in press).
15. Marshall V, Grosset D. Role of dopamine transporter imaging in routine clinical practice. Mov. Disord. 2003 18 : 1415 1423.
16. Schadt CR, Duffis EI, Charles D. Pharmacological treatment of disabling tremor. Expert Opin. 2005 6 : 419 428.
17. Grimes DA. Tremor: Easily seen but difficult to describe and treat. Can. J. Neurol. Sci. 2003 30 (Suppl. 1 59 63.
18. Wagstaff AJ, Cheer SM, Matheson AJ et al. Paroxetine: An update of its use in psychiatric disorders in adults. Drugs 2002 62 : 655 703.
19. Gelenberg AJ, Jefferson JW. Lithium tremor. J. Clin. Psychiatry 1995 56 : 283 287.
20. Carroll JA, Jefferson JW, Greist JH. Treating tremor induced by lithium. Hosp Community Psychiatry 1987 38 : 1280 1288.
21. Vestergaard P, Amiidsen A, Shou M. Clinically significant side effects of lithium treatment. A survey of 237 patients in long-term treatment. Acta Psychiatr. Scand. 1980 62 : 193 200.
22. Henry C. Lithium side-effects and predictors of hypothyroidism in patients with bipolar disorder: Sex differences. J. Psychiatry Neurosci. 2002 27 : 104 107.
23. Vestergaard P, Poulstrup I, Shou M. Prospective studies on a lithium cohort 3. Tremor, weight gain, diarrhea, psychological complains. Acta Psychiatr. Scand. 1988 78 : 434 441.
24. Dunner DL. Optimizing lithium treatment. J. Clin. Psychiatry 2000 61 (Suppl. 9 76 81.
25. Abou-Saleh MT, Coppen A. The efficacy of low-dose of lithium: Clinical, psychological and biological correlates. J. Psychiatr. Res. 1989 23 : 157 162.
26. Jefferson JW. Lithium tremor and caffeine intake: Two cases of drinking less and shaking more. J. Clin. Psychiatry 1988 49 : 72 73.
27. Zaninelli R, Bauer M, Jobert M et al. Changes in quantitatively assessed tremor during treatment of major depression with lithium augmented by paroxetine or amitriptyline. J. Clin. Psychopharmacol. 2001 21 : 190 198.
28. Stoudemire A, Hill CD, Levison BJ et al. Lithium intolerance in a medical-psychiatric population. Gen. Hosp. Psychiatry 1998 20 : 85 90.
29. Holroyd S, Smith D. Disabling parkinsonism due to lithium: A case report. J. Geriatr. Psychiatry Neurol. 1995 8 : 118 119.
30. Dallocchio C, Mazzarello P. A case of Parkinsonism due to lithium intoxicacion: Treatment with Pramipexole. J. Clin. Neurosci. 2002 9 : 310 311.
31. Karas BJ, Wilder BJ, Hammond EJ et al. Valproate tremors. Neurology 1982 32 : 428 432.
32. Hyman NM, Denis PD, Sinclair KG. Tremor due to sodium valproate. Neurology 1979 29 : 1177 1180.
33. Rinnerthaler M, Luef G, Muller J et al. Computerized tremor analysis of valproate-induced tremor: A comparative study of controlled-release versus conventional valproate. Epilepsia 2005 46 : 320 326.
34. Post RM, Ketter TA, Uhde T et al. Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness: Principles and practice. CNS Drugs 2007 21 : 47 71.
35. Goldsmith DR, Wagstaff AJ, Ibbotson T et al. Spotlight on lamotrigine in bipolar disorder. CNS Drugs 2004 18 : 63 67.
36. Siemes H, Branl U, Helmstadter C et al. Optimizing epilepsy therapy in children and adolescents with lamotrigine. Klin. Pediatr. 2005 21 : 222 229.
37. Smith WT, Glaudin V, Panagides J et al. Mirtazapine vs amitriptyline vs placebo in the treatment of major depressive disorder. Psychopharmacol. Bull. 1990 26 : 191 196.
38. Chouinard G. A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder. J. Clin. Psychiatry 1985 46 : 32 37.
39. Kronfol Z, Greden JF, Zis AP. Imipramine-induced tremor: Effects of a beta-adrenergic blocking agent. J. Clin. Psychiatry 1983 44 : 225 226.
40. Lejoyeux M, Rouillon F, Ades J et al. Neural symptoms induced by tricyclic antidepressant: Phenomenology and pathophysiology. Acta Psychiatr. Scand. 1992 85 : 249 256.
41. Edwards JG, Anderson L. Systematic review and guide to selection of selective serotonin reuptake inhibitors. Drugs 1999 57 : 507 557.
42. Diaz-Martinez A, Benassinni O, Ontiveros A et al. A randomised open-label comparison of velanfaxine and fluoxetine in depressed outpatients. Clin. Ther. 1998 20 : 467 476.
43. Wernicke JF. The side effect profile and safety of fluoxetine. J. Clin. Psychiatry 1985 46 : 59 67.
44. Serrano-Dueñas M. Fluoxetine-induced tremor: Clinical features in 21 patients. Parkinsonism Relat. Disord. 2002 8 : 325 327.
45. Boyer EW, Shannon M. The serotonin syndrome. N. Engl. J. Med. 2005 352 : 1112 1120.
46. Wirshing WC. Movement disorders associated with neuroleptic treatment. J. Clin. Psychiatry 2001 62 (Suppl. 21 15 18.
47. Jimenez-Jimenez FJ, Garcia-Ruiz PJ, Molina JA. Drug-induced movement disorders. Drug Saf. 1997 16 : 180 204.
48. Sethi KD. Movement disorders induced by dopamine blocking agents. Semin. Neurol. 2001 21 : 59 68.
49. Stacy M, Jankovic J. Tardive tremor. Mov. Disord. 1992 7 : 53 57.
50. Tarsy D, Baldessarini RJ, Tarazi FI. Effects of newer antipsychotics on extrapyramidal function. CNS Drugs 2002 16 : 23 45.
51. Chen JJ, Lee KC. Nonparkinsonism movement disorders in the elderly. Consult. Pharm. 2006 21 : 58 61.
52. Nguyen N, Pradel V, Micallef J et al. Drug-induced Parkinson syndromes. Therapie 2004 59 : 105 112.
53. Cipriani A, Rendell JM, Geddes JR. Haloperidol alone or in combination for acute mania. Cochrane Database Syst. Rev. 2006 3 : CD004362.
54. Gironell A. Estrategias terapéuticas en el temblor esencial. Med. Clin. (Barcelona) 2007 129 : 632 637.
55. Ceravolo R, Salvetti S, Piccini P et al. Acute and chronic effects of clozapine in essential tremor. Mov. Disord. 1999 14 : 468 472.
56. Ondo WG. Essential tremor: Treatment options. Curr. Treat. Options Neurol. 2006 8 : 256 267.
57. Koller WC, Histrova A, Brin M. Pharmacologic treatment of essential tremor. Neurology 2000 54 : 530 538.
58. Cleeves L, Findley LI. Propanolol and propanolol-LA in essential tremor. A double-blind comparative study. J. Neurol. Neurosurg. Psychiatry 1988 51 : 379 384.
59. Koller WC, Vetere-Overfield B. Acute and chronic effects of propanolol and primidone in essential tremor. Neurology 1989 39 : 1587 1588.
60. Kornischka J, Cordes J, Agelink MW. 40 Jahre Beta-Blocker in der Psychiatrie. Fortschr. Neurol. Psychiatr. 2007 75 : 199 210.
61. Dietrichson P, Espen E. Effects of timolol and atenolol on benign essential tremor: Placebo controlled studies based on quantitative tremor recording. J. Neurol. Neurosurg. Psychiatry 1981 33 : 677 683.
62. Koller WC. Nadolol in essential tremor. Neurology 1983 33 : 1076 1077.
63. Gorman WP, Cooper R, Pocock P et al. A comparison of primidone, propanolol, and placebo in essential tremor: A double-blind comparative study. J. Neurol. Neurosurg. Psychiatry 1986 49 : 64 68.
64. Connor GS. A double-blind placebo-controlled trial of topiramate treatment for essential tremor. Neurology 2002 59 : 132 134.
65. Huber SJ, Paulson GW. Efficacy of alprazolam for essential tremor. Neurology 1988 38 : 241 243.
66. Thomson C, Lang A, Parkers JD et al. A double-blind trial of clonazepam in benign essential tremor. Clin. Neuropharmacol. 1984 7 : 83 88.
67. Sheffield JK, Jankovic J. Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease. Expert Rev. Neurother. 2007 7 : 637 647.